Press Releases

QT Imaging Announces First Quarter 2024 Financial Results

Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th; Streamlined Business Model via Strategic Sales and Distribution Partnership in USA

QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ

QT Imaging Holdings, together with its strategic business and distribution partner, is proud to announce its partnership with The Vincere Cancer Center in Scottsdale, AZ.

QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell

QT Imaging is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square.

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

The study was published in Academic Radiology, online, in January 2024: A Multireader Multicase (MRMC) Receiver Operating Characteristic (ROC) Study Evaluating Noninferiority of Quantitative Transmission (QT) Ultrasound to Digital Breast Tomosynthesis (DBT) on Detection and Recall of Breast Lesions – Academic Radiology

QT Imaging’s Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer

The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care including cancer prevention, its early detection, and internal medicine. With the incorporation of the QT Imaging Breast Acoustic CT™ Scanner, the Center for New Medicine will expand their innovative services in women’s and breast health.

QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer

QT Imaging Holdings, Inc. a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that the Board of Directors has appointed former GigCapital5, Inc. CEO Dr. Raluca Dinu as Active Chief Executive Officer and member of the Board of Directors, effective March 12, 2024.

QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

QT Imaging is pleased to announce the delivery of a Breast Acoustic CT™ Scanner under a unique collaboration with the Department of Radiation Oncology, and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada, one of the largest cancer centers in Canada, and The University of Illinois, Urbana-Champaign, Department of Electrical and Computer Engineering and Grainger College of Engineering. This collaboration is part of a five-year research grant from National Institutes of Health/National Cancer Institute to develop an inexpensive, portable, safe, and repeatable imaging approach capable of accurate and early identification of response of breast cancer patients to neoadjuvant chemotherapy (NAC).

QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership

QT Imaging announces the first commercial sale of a QTI Breast Acoustic CT System to True Health Center for Functional Medicine. QTI’s inaugural customer was born as a result of the collaboration with our previously announced strategic distribution partner and represents the business model to be deployed by the company.

QT Imaging Holdings Announces Completion of Business Combination with GigCapital5

QT Imaging Holdings Expected to Begin Trading on NASDAQ Under Ticker Symbol “QTI” on March 5, 2024

QT Imaging Announces Publication of First Whole Body Imaging Results Using Low Frequency Transmission Ultrasound

QT Imaging to Present at the 3rd Annual B. Riley Securities Oncology Conference

QT Imaging CEO to present at leading conference on cancer treatment, testing, and monitoring modalities

QT Imaging and GigCapital5 to Merge

QT Imaging and GigCapital5 to Merge

QT Imaging and GigCapital5 Announce Signing of Business Combination Agreement to Bring Breast and Full Body Imaging Solutions to the Public Markets

GigCapital5 and QT Imaging have entered into a definitive business combination agreement that would result in QT Imaging becoming a publicly listed company

QT Imaging, the University of Illinois, and the Sunnybrook Research Institute Receive $3.1 Million National Cancer Institute Grant for Breast Cancer Treatment Monitoring

The QTscan to be used to improve the assessment of tumor response in neo-adjuvant chemotherapy treatments

GigCapital5 and QT Imaging Sign an Exclusive Term Sheet for a Business Combination

QT Imaging expected to be public in the first half of 2023

FDA Grants QT Imaging™ Clearance to Calculate Fibroglandular Volume of the Breast

QTscan delivers safe, accurate monitoring of breast cancer treatment.

QT Imaging Quantifies Changes in Breast Glandular and Ductal Volume During Menstrual Cycle

Study provides a more accurate description of tissue changes during the menstrual cycle – the first time such observations have been made in vivo.

National Cancer Institute Prostate Cancer Screening Study Indicates QTscan® Has Equal or Better Sensitivity Than MRI

QT Imaging’s low frequency transmitted ultrasound volography™ had sensitivity of 85.7% sensititivity compared to mpMRI at 65.3% in a blinded sector-based analysis.

QT Imaging Announces Second Blinded Screening Trial Finding Non-Inferiority to Mammography

QT Imaging meets non-inferiority endpoint for mass detection when compared to conventional full field digital mammography (FFDM)

US Capital Global Securities Launches $10MM Convertible Note Offering QT Imaging, Inc

US Capital Global Securities engaged as lead placement agent by innovative MedTech company developing new-paradigm ultrasound technology for breast cancer screening.

Transmission Ultrasound Breast Imaging to Become Available in EMEA Markets

QT Imaging signs distribution agreement with Freedom Ventures for its FDA-cleared breast scanner

Quantitative Transmission Ultrasound Research Shows Better Performance than Mammography

First-in-class, first-in-human study compares new breast imaging modality to digital mammography

QT Ultrasound to Bring Breast Imaging Innovation to Asia Through Joint Venture with TCL Healthcare Equipment

Common mission of safe, advanced, affordable medical imaging brings together international leaders

QT Ultrasound Leaders to Present Breakthrough Research on Breast Imaging Technology

CEO, John Klock, MD, and Principal Scientist, James Wiskin, Ph.D, Present Innovation in Quantitative Transmission Ultrasound

Quantitative Transmission Ultrasound to be Featured at Acoustical Society of America

James Wiskin, Ph.D, QT Ultrasound’s Principal Scientist, invited to lecture on innovative technology

QT Ultrasound Delivers the First 3D Printing of Human Breast Microanatomy In Vivo

3D Transmission Ultrasound Technology Advances How We Look at Breast Health

Quantitative Transmission Ultrasound Featured Throughout SPIE Medical Imaging Conference

QT Ultrasound’s principal scientists and technologists deliver five presentations at key industry event

QT Ultrasound® Presents Breakthrough Research Results on Quantitative Transmission Ultrasound

Chief Medical Officer, Rajni Natesan, MD, MBA and Principal Scientist, Bilal Malik, Ph.D, will introduce cutting edge research at RSNA 2018

FDA Grants QT Ultrasound® Breakthrough Device Designation

The FDA has designated the QT Ultrasound Breast Scanner as meeting an unmet medical need for screening women at high risk for breast cancer

QT Ultrasound receives FDA clearance for new QTviewer

As part of the QT Ultrasound Breast Scanner the new viewer for true 3D breast images offers radiologists clarity, customizable views, faster response time, and powerful research mode.

FDA clearance granted to QT Ultrasound for new breast imaging device

Transmission ultrasound technology provides 360-degree images and a new level of clarity for breast scans, without breast compression.

Skip to content